Início › Diabetes tipo 2 › Alabama › Birmingham
Ensaios clínicos de Diabetes tipo 2 em Birmingham, AL
16 estudos para Diabetes tipo 2 estão buscando participantes em locais em Birmingham e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)
Recrutando
- University of Alabama, Birmingham
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)
Recrutando
- University of Alabama, Birmingham
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
RecrutandoFase 3
- Cahaba Research, Inc. - Trussville Location, Birmingham
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
RecrutandoFase 3
- Birmingham Clinical Research, Birmingham
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
RecrutandoFase 3
- AURORA-2 Clinical Site, Birmingham
A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
RecrutandoFase 2
- Central Research Associates - Flourish - PPDS, Birmingham
- AES - DRS - Synexus Clinical Research US, Inc. - Birmingham, Birmingham
A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
RecrutandoFase 2
- Flourish Research, Birmingham
Advancing Diabetes Management for People With Physical Disabilities Optimally Through Primary Care-Based Telehealth (ADDOPT)
Recrutando
- UAB Highlands Hospital/Department of Family and Community Medicine, Birmingham
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
RecrutandoFase 3
- Research Site, Birmingham
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
RecrutandoFase 3
- Univ of Alabama Birmingham, Birmingham
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
RecrutandoFase 3
- Research Site, Birmingham
CGM for Management of Type 2 Diabetes in Pregnancy
Recrutando
- University of Alabama at Birmingham, Birmingham
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy
RecrutandoFase 2
- Central Research Associates, LLC dba Flourish Research, Birmingham
DISCOVERY of Risk Factors for Type 2 Diabetes in Youth
RecrutandoEstudo observacional
- University of Alabama at Birmingham, Birmingham
FELLAShip to Better Health
Recrutando
- The Worship Center Cristian Church, Birmingham
A Low-Carb Approach to Treat Type 2 Diabetes in Pediatric Patients
Recrutando
- University of Alabama at Birmingham/ Children's of Alabama, Birmingham
Ensaios de Diabetes tipo 2 em outras cidades
- San Antonio, TX37 estudos
- Houston, TX31 estudos
- Orlando, FL24 estudos
- Boston, MA20 estudos
- Miami, FL19 estudos
- Chicago, IL19 estudos
- Dallas, TX19 estudos
- Columbus, OH18 estudos
- Las Vegas, NV18 estudos
- Atlanta, GA17 estudos
- San Diego, CA17 estudos
- Los Angeles, CA16 estudos
Outros estudos em Birmingham
- Câncer (todos os tipos)30 estudos
- Câncer de Mama24 estudos
- Obesidade23 estudos
- Câncer de Ovário23 estudos
- Câncer de Pulmão de Não Pequenas Células22 estudos
- Leucemia Mieloide Aguda21 estudos
- Mieloma Múltiplo18 estudos
- DPOC17 estudos
- Doença Cardiovascular17 estudos
- Sobrepeso16 estudos
- Câncer Endometrial16 estudos
- Fibrose Cística16 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.